(R)-4-(3'-chlorobiphenyl-4-yl)-3-[(oxazole-5-carbonyl)-amino]-butyric acid | 1257445-73-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (R)-4-(3'-chlorobiphenyl-4-yl)-3-[(oxazole-5-carbonyl)-amino]-butyric acid
• 英文别名: (3R)-4-[4-(3-chlorophenyl)phenyl]-3-(1,3-oxazole-5-carbonylamino)butanoic acid
• CAS: 1257445-73-0
• 化学式: C₂₀H₁₇ClN₂O₄
• 分子量: 384.819
• InChiKey: ZZGFJHBKUFEXDU-QGZVFWFLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  27
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  92.4
• 氢给体数：
  2
• 氢受体数：
  5

文献信息

• ISOPRENE OLIGOMER, POLYISOPRENE, PROCESSES FOR PRODUCING THESE MATERIALS, RUBBER COMPOSITION, AND PNEUMATIC TIRE
  申请人：Miyagi Yukino

  公开号：US20140171675A1

  公开（公告）日：2014-06-19

  The invention relates to an isoprene oligomer that contains a trans structural moiety and a cis structural moiety, which can be represented by the following formula (1), wherein at least 1 atom or group in the trans structural moiety is replaced by another atom or group. The invention also relates to a polyisoprene, which is biosynthesized using the isoprene oligomer and isopentenyl diphosphate. Further, this invention provides a rubber composition comprising the isoprene oligomer and/or the polyisoprene, and a pneumatic tire, including tire components (e.g., treads and sidewalls) formed from the rubber composition. wherein n represents an integer from 1 to 10; m represents an integer from 1 to 30; and Y represents a hydroxy group, a formyl group, a carboxy group, an ester group, a carbonyl group, or a group represented by the following formula (2):

  该发明涉及一种含有反式结构基团和顺式结构基团的异戊二烯寡聚物，可以用以下公式（1）表示，其中反式结构基团中至少有1个原子或基团被另一个原子或基团取代。该发明还涉及一种聚异戊二烯，它是使用异戊二烯寡聚物和异戊二烯二磷酸盐生物合成的。此外，该发明提供了一种橡胶组合物，包括异戊二烯寡聚物和/或聚异戊二烯，以及一种充气轮胎，其中轮胎组件（例如胎面和侧壁）由该橡胶组合物形成。 其中n表示1到10之间的整数；m表示1到30之间的整数；Y表示一个羟基、一个甲酰基、一个羧基、一个酯基、一个酰基或由以下公式（2）表示的基团。
• [EN] PROCESS FOR PREPARING SULFONAMIDE COMPOUNDS<br/>[FR] PROCÉDÉ DE PRÉPARATION DE COMPOSÉS DE SULFONAMIDE
  申请人：ASCENTAGE PHARMA SUZHOU CO LTD

  公开号：WO2020140956A1

  公开（公告）日：2020-07-09

  Provided are a process for preparing a sulfonamide compound which is an inhibitor of Bcl-2/Bcl-xL, including the compound (3R) -1- (3- (4- (4- (4- (3- (2- (4-chlorophenyl) -1-isopropyl-4-methylsulfonyl-5-methyl-1H-pyrrol-3-yl) -5-fluorophenyl) piperazine -1-yl) -phenylaminosulfonyl) -2-trifluoromethanesulfonyl-anilino) -4-ph enylthio-butyl) -piperidine-4-carboxylic acid 3-phosphonopropyl ester, an intermediate for preparing the sulfonamide compound and a preparation process thereof.

  提供了一种制备硫酰胺化合物的过程，该化合物是Bcl-2/Bcl-xL的抑制剂，包括化合物(3R)-1-(3-(4-(4-(4-(3-(2-(4-氯苯基)-1-异丙基-4-甲基磺酰基-5-甲基-1H-吡咯-3-基)-5-氟苯基)哌嗪-1-基)-苯胺磺酰基)-2-三氟甲磺酰基苯胺基)-4-苯硫基-丁基)-哌啶-4-羧酸3-磷酸丙基酯，用于制备硫酰胺化合物的中间体及其制备过程。
• SUBSTITUTED AMINOPROPIONIC DERIVATIVES AS NEPRILYSIN INHIBITORS
  申请人：COPPOLA Gary Mark

  公开号：US20140296240A1

  公开（公告）日：2014-10-02

  The present invention provides a compound of formula I′; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , B 1 , X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了式I'的化合物；或其药学上可接受的盐，其中R1、R2、R3、R5、B1、X和n在此定义。本发明还涉及制造本发明化合物的方法及其治疗用途。本发明还提供了一种药理活性剂的组合和制药组合物。
• Substituted Aminopropionic Derivatives as Neprilysin inhibitors
  申请人：Coppola Gary Mark

  公开号：US20100305131A1

  公开（公告）日：2010-12-02

  The present invention provides a compound of formula I′; or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , R 3 , R 5 , B 1 , X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了式I'的化合物；或其药学上可接受的盐，其中R1、R2、R3、R5、B1、X和n在此定义。本发明还涉及制造该化合物的方法及其治疗用途。本发明进一步提供了一种药理活性剂的组合和制药组合物。
• Substituted aminopropionic derivatives as neprilysin inhibitors
  申请人：Novartis AG

  公开号：EP2594556A1

  公开（公告）日：2013-05-22

  The present invention provides a compound of formula I'; or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R5, B1, X and n are defined herein. The invention also relates a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种式 I' 的化合物； 或其药学上可接受的盐，其中 R1、R2、R3、R5、B1、X 和 n 在本文中定义。本发明还涉及一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了药理活性剂和药物组合物的组合。